Tampa-headquartered Arfinn Med has launched its clinician-based, medical cannabis efficacy portal to help licensed medical professionals track, report and share benchmark data for prescribing medical cannabis to patients.
“As a free tool for physicians, Arfinn Med offers a new way to enhance treatment plans and practices in an emerging industry,” notes a statement from the full-service medical education company. The shared data must be compliant with the U.S. Health Insurance Portability and Accountability Act of 1996.
Within the portal—which include the components: reports, community, industry news and resources—“medical professionals can obtain peer-based reports on treatment effectiveness, daily dosage, delivery method and other information specific to patient demographics,” the company reports. As well, medical professionals will have access to industry news, trends, specialized groups, forums, blogs and other medical research.
“Any licensed medical professional is able to register for the portal for free, regardless of state location and medical marijuana legalization,” the statement notes, adding that the platform was rolled out to select physicians last October.
A “patient engagement tool to allow physicians to communicate in real-time with patients about their treatment plans and outcomes, increasing efficacy rates and the probability that patients return to their prescribing physician’s practice,” the company adds.